₹26.94 crore. The company has fixed the price band for the issue at ₹51-52 per share. The lot size for Asarfi Hospital IPO is 2,000 shares and the minimum investment amount required for retail investors is ₹104,000.
The company will finalise the IPO share allotment on July 24 and initiate refunds on July 25. The credit of shares to the demat accounts will take place on July 26. Asarfi Hospital shares are expected to list on July 27 at BSE SME, a platform for small and medium enterprises.
Also Read: Senco Gold shares list at ₹430 per share on NSE. Buy, sell or hold after strong debut? Hem Securities Limited is the Book Running Lead Manager to the public issue while Cameo Corporate Services is the IPO registrar. In the Asarfi Hospital IPO, 50% of the shares are reserved for Qualified Institutional Buyers (QIB), 15% for Non-Institutional Investors and remaining 35% for retail investors.
Asarfi Hospital is a 250 bedded multi-specialty hospital with 23 departments. It has 70 doctors and 242 nursing staff and 481 other staff. Its top revenue generating specialties are Cardiology, Neurosciences, General Medicine, Paediatrics & Obstetrics.
The Hospital has been serving people for over 15 years in Dhanbad in the eastern state of Jharkhand Also Read: Alphalogic Industries shares make a flat debut on BSE SME, lists at ₹96 It added that a new 50 bedded dedicated Cancer Hospital is currently under construction in Dhanbad. In FY23, the company achieved revenue from operations of ₹70.7 crore with EBITDA ₹13.77 crore and net profit of ₹8.01 crore. It had an average revenue per occupied bed (ARPOB) of ₹20,068 with Average bed occupancy rate of 65% and average length of stay 4 days, the company said in a statement.
Read more on livemint.com